Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1222523A details a novel route for 9-amino camptothecin, recycling 12-nitro byproducts to ensure cost reduction in pharmaceutical manufacturing and high purity.
Advanced synthesis of double-labeled Furmonertinib for ADME studies. Enhances tracer sensitivity and supply chain reliability for pharmaceutical R&D teams.
Patent CN106458892B details improved duocarmycin prodrug synthesis using organolithium reagents offering significant supply chain and cost advantages for ADC manufacturing.
Novel microwave method for Rapamycin 40-hydroxy alkylation. Higher yield, lower cost. Reliable pharmaceutical intermediates supplier for large scale-up.
Patent CN110845406A reveals a safer quinoline synthesis avoiding phosphorus oxychloride. Ideal for tyrosine kinase inhibitor manufacturing with reduced waste and high purity.
Novel Cu-catalyzed route for Flumatinib intermediate CN111763170A. Eliminates genotoxic impurities, reduces cost, ensures supply continuity for API manufacturing.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Patent CN1930117A details a scalable low-temperature oxidation process for AQ4N, reducing impurities and enhancing supply chain reliability for pharmaceutical intermediates.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Patent CN111032650A details a safer, scalable route for EGFR inhibitor intermediates, eliminating hazardous sodium hydride and iron reduction for cost-effective manufacturing.
Patent CN116178375B details a novel 5-step synthesis for anti-prostate cancer intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of cMet inhibitor intermediates via patent CN105712992B. Offers scalable routes for oncology API manufacturing with enhanced supply chain reliability.
Discover a novel N-to-C synthesis route for Carfilzomib avoiding racemization. High yield, chromatography-free purification for cost-effective API manufacturing.
Novel Idelalisib preparation method offers significant cost reduction and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking high-purity APIs.
Patent CN108948080B reveals a safer triethylsilane-based route for fosaprepitant dimeglumine, offering high purity and scalable manufacturing for global supply chains.
Patent CN106854200A details a high-yield Ceritinib synthesis route eliminating Boc protection steps, ensuring high-purity pharmaceutical intermediates and supply chain reliability.
Patent CN113583088A details novel cyclic peptide synthesis targeting STRN3 for gastric cancer, offering improved stability and cell permeability for pharmaceutical manufacturing.
Patent CN1033589C details a scalable synthesis of etoposide phosphate using haloacetyl protection, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106854182B reveals a high-yield, one-pot synthesis for 2,5-dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine, offering significant cost reduction in API manufacturing.
Advanced 3-step synthesis of naphthoyl amine derivatives for kinase inhibitors. Reliable pharmaceutical intermediate supplier offering cost-effective, scalable routes.